Cargando…
No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial
BACKGROUND: The objective of this study was to assess the benefit of temporary combination antiretroviral therapy (cART) during primary HIV infection (PHI). METHODS AND FINDINGS: Adult patients with laboratory evidence of PHI were recruited in 13 HIV treatment centers in the Netherlands and randomly...
Autores principales: | Grijsen, Marlous L., Steingrover, Radjin, Wit, Ferdinand W. N. M., Jurriaans, Suzanne, Verbon, Annelies, Brinkman, Kees, van der Ende, Marchina E., Soetekouw, Robin, de Wolf, Frank, Lange, Joep M. A., Schuitemaker, Hanneke, Prins, Jan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313945/ https://www.ncbi.nlm.nih.gov/pubmed/22479156 http://dx.doi.org/10.1371/journal.pmed.1001196 |
Ejemplares similares
-
Temporary Treatment during Primary HIV Infection Does Not Affect Virologic Response to Subsequent Long-Term Treatment
por: Grijsen, Marlous L., et al.
Publicado: (2014) -
batiment SHM18|building SHM18
por: Valeriane Duvivier
Publicado: (2001) -
HIV-1 dual infection is associated with faster CD4+T cell decline in a cohort of men with primary HIV infection
por: Cornelissen, Marion, et al.
Publicado: (2011) -
batiment SHM|SHM building|Cold box|Boite froide
por: Valeriane Duvivier
Publicado: (2001) -
batiment SHM|SHM building|Cold box|Boite froide
por: Valeriane Duvivier
Publicado: (2001)